As a full-service Clinical Research Organization (CRO), we deliver end-to-end clinical trial solutions across all phases of drug, nutraceutical, Cosmetic and medical device development — from First-in-Human (Phase I) to Post-Marketing Surveillance (Phase IV).

Our Expertise Includes:

• Phase I – Safety & Tolerability:
  • Early-stage trials in healthy volunteers or patients to evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD).
• Phase II – Efficacy & Dose Optimization:
  • Proof-of-concept studies to determine therapeutic efficacy, establish optimal dosing, and assess short-term safety in patient populations.
• Phase III – Confirmatory Trials:
  • Pivotal, large-scale trials conducted at multiple centers to confirm efficacy, monitor adverse reactions, and gather comprehensive data for regulatory submissions.
• Phase IV – Post-Marketing Surveillance:
  • Real-world evidence generation, long-term safety tracking, and support for additional indications, market access, and risk management.

With a highly experienced team, cutting-edge technologies, and a commitment to compliance with ICH-GCP, ISO 14155, and regional regulatory standards, we ensure efficient, ethical, and high-quality clinical research delivery.